Correlation Between AN2 Therapeutics and Foghorn Therapeutics
Can any of the company-specific risk be diversified away by investing in both AN2 Therapeutics and Foghorn Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AN2 Therapeutics and Foghorn Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AN2 Therapeutics and Foghorn Therapeutics, you can compare the effects of market volatilities on AN2 Therapeutics and Foghorn Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AN2 Therapeutics with a short position of Foghorn Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of AN2 Therapeutics and Foghorn Therapeutics.
Diversification Opportunities for AN2 Therapeutics and Foghorn Therapeutics
-0.17 | Correlation Coefficient |
Good diversification
The 3 months correlation between AN2 and Foghorn is -0.17. Overlapping area represents the amount of risk that can be diversified away by holding AN2 Therapeutics and Foghorn Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Foghorn Therapeutics and AN2 Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AN2 Therapeutics are associated (or correlated) with Foghorn Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Foghorn Therapeutics has no effect on the direction of AN2 Therapeutics i.e., AN2 Therapeutics and Foghorn Therapeutics go up and down completely randomly.
Pair Corralation between AN2 Therapeutics and Foghorn Therapeutics
Given the investment horizon of 90 days AN2 Therapeutics is expected to generate 1.39 times more return on investment than Foghorn Therapeutics. However, AN2 Therapeutics is 1.39 times more volatile than Foghorn Therapeutics. It trades about 0.21 of its potential returns per unit of risk. Foghorn Therapeutics is currently generating about -0.06 per unit of risk. If you would invest 110.00 in AN2 Therapeutics on August 29, 2024 and sell it today you would earn a total of 29.00 from holding AN2 Therapeutics or generate 26.36% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
AN2 Therapeutics vs. Foghorn Therapeutics
Performance |
Timeline |
AN2 Therapeutics |
Foghorn Therapeutics |
AN2 Therapeutics and Foghorn Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with AN2 Therapeutics and Foghorn Therapeutics
The main advantage of trading using opposite AN2 Therapeutics and Foghorn Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AN2 Therapeutics position performs unexpectedly, Foghorn Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Foghorn Therapeutics will offset losses from the drop in Foghorn Therapeutics' long position.AN2 Therapeutics vs. Eliem Therapeutics | AN2 Therapeutics vs. Scpharmaceuticals | AN2 Therapeutics vs. Milestone Pharmaceuticals | AN2 Therapeutics vs. Seres Therapeutics |
Foghorn Therapeutics vs. C4 Therapeutics | Foghorn Therapeutics vs. Prelude Therapeutics | Foghorn Therapeutics vs. Rezolute | Foghorn Therapeutics vs. Shattuck Labs |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data |